Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Cell growth switch enhances stem cell gene therapy

Sep. 18, 2000

Screening collaboration between CDD and CST to identify novel kinase inhibitors

Sep. 14, 2000

Synthetic antioxidant compounds extend the life span of C. elegans

Sep. 14, 2000

GlycoDesign and Seikagaku expand drug development agreement

Sep. 14, 2000

Medarex and Oxford GlycoSciences to codevelop human antibody therapeutics

Sep. 14, 2000

ImmunoGen and Abgenix form multiproduct collaboration

Sep. 12, 2000

Pherin and Taisho establish vomeropherin collaboration

Sep. 8, 2000

New phosphodiester analogue synthesized at Duke

Sep. 7, 2000

Novel approach to identifying therapeutic targets and high-affinity ligands/substrates

Sep. 7, 2000

Supratek's SP-1017 shown to significantly increase gene expression

Sep. 5, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...